Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now full pipeline small index

Hip Dysplasia: full-pipeline trial registry

5 of 6 indexed Hip Dysplasia trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 5 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Hip Dysplasia: 6 US clinical trials tracked, 5 recruiting.

Hip Dysplasia is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Mayo Clinic, running 2 of these trials.

Enrollment posture brief

Registry condition hip-dysplasia

OPEN 5 | RECR 83% | LATE 1 | EARLY 1 | RANK #2866 | SPON 2

Nearest open-share peer: Alcoholic Hepatitis (83% recruiting · 6 trials)

Hip Dysplasia (this)83%Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%
Open-enrollment share among volume-matched conditions near Hip Dysplasia

Hip Dysplasia lists 5 open slots (83% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hip Dysplasia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hip Dysplasia is recruiting above its size-band peers.

    5 of 6 indexed trials (83.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Hip Dysplasia research.

    Mayo Clinic accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Hip Dysplasia enrolment sits around 120 participants.

    Median target enrolment is 120 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.

  4. Hip Dysplasia research is mostly interventional.

    5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 41

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 1

Named interventions

Most-linked intervention names on Hip Dysplasia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Long-term Follow-up Surveys Other
1 trials
Ropivacaine, Epinephrine, Ketorolac, NaCl (Saline) Combination
1 trials
PAO without hip arthroscopy Procedure
1 trials
PAO with hip arthroscopy Procedure
1 trials
Periacetabular osteotomy with hip arthroscopy Procedure
1 trials
Periacetabular osteotomy Procedure
1 trials
ReNew Hip Implant Device
1 trials
Bupivacaine, lidocaine, ropivacaine Drug
1 trials

US sites by state

Facility locations filed on Hip Dysplasia trials. A trial with sites in several states counts in each.

Missouri 2 trials
Minnesota 2 trials
Illinois 2 trials
New York 1 trials
Michigan 1 trials
Iowa 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hip Dysplasia page

6 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 5 Hip Dysplasia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Mayo Clinic sponsors the most Hip Dysplasia trials on record, review their full trial history before evaluating a specific study. See Mayo Clinic's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hip Dysplasia condition card totals 6 registered trials; most-linked intervention Long-term Follow-up Surveys; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.